Identifying the target NSCLC patient for maintenance therapy: An analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†
C. Obasaju, L. Bowman, P. Wang, W. Shen, K. B. Winfree, E. N. Smyth, M. E. Boye, W. John, T. Brodowicz, C. P. Belani
Dive into the research topics of 'Identifying the target NSCLC patient for maintenance therapy: An analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†'. Together they form a unique fingerprint.